ConductScience.org, home
GUCY2C: guanylate cyclase 2C
API referenceFor AI assistants

Gene · 2984

Papers1,157

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,157

Download this page as JSON
TitleJournalYearPMIDFound bySource
A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers.Cancer Res Commun202642696650PubTator, text miningPubMed
Human bronchial air-liquid interface responses to nebulised protease exposure.Front Immunol202642630249PubTator, text miningPubMed
Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform.Technol Cancer Res Treat202642579767PubTator, text miningPubMed
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.Cancer Biol Ther202642502958PubTator, text miningPubMed
Nonarmored GCC-Targeting CAR T-cell Therapy Demonstrates Significant Efficacy in Patients with Advanced Colorectal Cancer.Clin Cancer Res202642467218PubTator, text miningPubMed
Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.ESMO Open202642462280PubTator, text miningPubMed
Establishing scientific confidence: human biological relevance of reconstructed human respiratory epithelium (RHRE) for assessing respiratory effects.Front Toxicol202642344759PubTator, text miningPubMed
De novo activating GUCY2C variant with prenatal bowel dilatation, neonatal functional obstruction, and reversible intestinal failure: A case report.Intest Fail202642318326PubTator, text miningPubMed
Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.J Clin Oncol202642241671PubTator, text miningPubMed
Sex-specific regulation of angiogenin in Alzheimer's disease.Mol Psychiatry202642230965PubTator, text miningPubMed
Real-World Traffic-Polluted Air and Its Impact on a 3D Model of the Human Airway Epithelium.J Xenobiot202642201086PubTator, text miningPubMed
Using simple to more robust in vitro methods based on human pulmonary models to evaluate the acute and subacute toxicity of micro- and nanoplastics derived from 3D printing materials.NanoImpact202642134510PubTator, text miningPubMed
Efficacy and safety of Guanylyl cyclase C agonists (linaclotide and plecanatide) in patients with irritable bowel syndrome with constipation: a systematic review and meta-analysis of randomized controlled trials.
Front Pharmacol202642038325PubTator, text miningPubMed
IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy.Front Immunol202641924255PubTator, text miningPubMed
Human Organoids and Organ-on-Chip for Biotoxin Assessment: Applications, Best Practices, and a Translational Roadmap.Toxins (Basel)202641893572PubTator, text miningPubMed
A Composite interaction Score: Prioritizing cell-cell interactions from single-cell RNA-seq with application to pre-menopausal epithelial barriers.J Adv Res202641875947PubTator, text miningPubMed
Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies.World J Clin Oncol202641810338PubTator, text miningPubMed
Immunotherapy for microsatellite-stable colorectal cancer: overcoming resistance and exploring novel therapeutic strategies.Ann Coloproctol202641802306PubTator, text miningPubMed
Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders.Int J Med Sci202641799760PubTator, text miningPubMed
Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology.Front Bioeng Biotechnol202641768137PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2984/papers

API referenceFor AI assistants